Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Kini

Showing results (201-210 of 250) with videos related to

Pageof 25
Sort By:
Atherosclerosis|June 30, 2026
Serial OCT-based coronary physiology and plaque composition in vessels with nonobstructive coronary lesions following intensive lipid-lowering therapy: YELLOW III sub-studyPruthvi C Revaiah, Yuliya Vengrenyuk, Vemuri Krishna Santosh, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 25, 2013
Comparison of six risk scores in patients with triple vessel coronary artery disease undergoing PCI: competing factors influence mortality, myocardial infarction, and target lesion revascularizationJason C Kovacic, Atul M Limaye, Samantha Sartori, et al.
JACC. Cardiovascular Interventions|May 7, 2021
Outcomes of Prosthesis-Patient Mismatch Following Supra-Annular Transcatheter Aortic Valve Replacement: From the STS/ACC TVT RegistryGilbert H L Tang, Aditya Sengupta, Sophia L Alexis, et al.
International Journal of Cardiology|April 16, 2014
Dedicated two-stent technique in complex bifurcation percutaneous coronary intervention with use of everolimus-eluting stents: the EES-bifurcation studyNisharahmed I Kherada, Samantha Sartori, Matthew I Tomey, et al.
European Heart Journal. Imaging Methods and Practice|June 22, 2026
Intra-coronary imaging and transcriptomics of calcified nodules before and after intensive lipid-lowering therapy: a YELLOW III substudyPruthvi C Revaiah, Yuliya Vengrenyuk, JiaJia Liu, et al.
Thrombosis and Haemostasis|May 17, 2013
Combined and independent impact of diabetes mellitus and chronic kidney disease on residual platelet reactivityUsman Baber, Jeffrey Bander, Rucha Karajgikar, et al.
JACC. Cardiovascular Interventions|July 9, 2016
Time-Dependent Associations Between Actionable Bleeding, Coronary Thrombotic Events, and Mortality Following Percutaneous Coronary Intervention: Results From the PARIS RegistryUsman Baber, George Dangas, Jaya Chandrasekhar, et al.
JACC. Advances|June 28, 2024
Sex Differences Among Patients Receiving Edoxaban vs Vitamin K Antagonist for Atrial Fibrillation After TAVRRoxana Mehran, Alessandro Spirito, James Jin, et al.
Journal of Thrombosis and Thrombolysis|August 13, 2021
Perioperative risk and antiplatelet management in patients undergoing non-cardiac surgery within 1 year of PCIDavide Cao, Matthew A Levin, Samantha Sartori, et al.
JACC. Cardiovascular Interventions|August 2, 2016
Sex-Based Differences in Cessation of Dual-Antiplatelet Therapy Following Percutaneous Coronary Intervention With StentsJennifer Yu, Usman Baber, Ioannis Mastoris, et al.
Pageof 25

Showing results (201-210 of 250) with videos related to

Sort By:
Pageof 25
Atherosclerosis|June 30, 2026
Serial OCT-based coronary physiology and plaque composition in vessels with nonobstructive coronary lesions following intensive lipid-lowering therapy: YELLOW III sub-studyPruthvi C Revaiah, Yuliya Vengrenyuk, Vemuri Krishna Santosh, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 25, 2013
Comparison of six risk scores in patients with triple vessel coronary artery disease undergoing PCI: competing factors influence mortality, myocardial infarction, and target lesion revascularizationJason C Kovacic, Atul M Limaye, Samantha Sartori, et al.
JACC. Cardiovascular Interventions|May 7, 2021
Outcomes of Prosthesis-Patient Mismatch Following Supra-Annular Transcatheter Aortic Valve Replacement: From the STS/ACC TVT RegistryGilbert H L Tang, Aditya Sengupta, Sophia L Alexis, et al.
International Journal of Cardiology|April 16, 2014
Dedicated two-stent technique in complex bifurcation percutaneous coronary intervention with use of everolimus-eluting stents: the EES-bifurcation studyNisharahmed I Kherada, Samantha Sartori, Matthew I Tomey, et al.
European Heart Journal. Imaging Methods and Practice|June 22, 2026
Intra-coronary imaging and transcriptomics of calcified nodules before and after intensive lipid-lowering therapy: a YELLOW III substudyPruthvi C Revaiah, Yuliya Vengrenyuk, JiaJia Liu, et al.
Thrombosis and Haemostasis|May 17, 2013
Combined and independent impact of diabetes mellitus and chronic kidney disease on residual platelet reactivityUsman Baber, Jeffrey Bander, Rucha Karajgikar, et al.
JACC. Cardiovascular Interventions|July 9, 2016
Time-Dependent Associations Between Actionable Bleeding, Coronary Thrombotic Events, and Mortality Following Percutaneous Coronary Intervention: Results From the PARIS RegistryUsman Baber, George Dangas, Jaya Chandrasekhar, et al.
JACC. Advances|June 28, 2024
Sex Differences Among Patients Receiving Edoxaban vs Vitamin K Antagonist for Atrial Fibrillation After TAVRRoxana Mehran, Alessandro Spirito, James Jin, et al.
Journal of Thrombosis and Thrombolysis|August 13, 2021
Perioperative risk and antiplatelet management in patients undergoing non-cardiac surgery within 1 year of PCIDavide Cao, Matthew A Levin, Samantha Sartori, et al.
JACC. Cardiovascular Interventions|August 2, 2016
Sex-Based Differences in Cessation of Dual-Antiplatelet Therapy Following Percutaneous Coronary Intervention With StentsJennifer Yu, Usman Baber, Ioannis Mastoris, et al.
Pageof 25